Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis For Up to 3 Years: An Open-Label Extension of Randomized Clinical Trials

Peng DS, Dong E, Seivright J, Gates G, Nguyen MO. Photosensitive symmetric papules of the nasal alae. JAAD Case Rep. 2026 Jan 21;70:253-255. doi: 10.1016/j.jdcr.2026.01.017.[...]

Murrell DF, Boucher D, Daneshpazhooh M, Mahmoudi H, Kianfar N, Dasdar S, Yale M, Wilson A, Bilgic A, Uzun S, Chandran NS, Patsatsi A, Drenovska[...]

Armstrong AW, Krueger JG, Strober BE, Stein Gold LF, Desai SR, Muscianisi E, Klyachkin Y, Ucpinar S, Tilley MK, Blauvelt A. Envudeucitinib, a Potent, Next-Generation,[...]